Abstract
The formation of antianginal pharmacotherapy has gone a long way, characterized by the search for the main factors of effective pharmacodynamics. The article presents an analysis of the use of drugs with different pharmacological properties in patients suffering from angina pectoris in a historical aspect, shows the evolution of researchers’ ideas about the mechanism of antianginal action, and gives a brief description of modern antianginal drugs. Analysis of the features of drug treatment of chronic coronary insufficiency with angina attacks gives reason to say that the development of pharmacology in this section of cardiology is in the direction of improvement, first of all, in the pharmacokinetic aspect of already known drugs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
